Related Articles
Expression of immune regulatory factors, chemokines and growth factors in differentiated gastric cancer cells treated with an anticancer bioactive peptide combined with oxaliplatin
New bioactive peptide reduces the toxicity of chemotherapy drugs and increases drug sensitivity
Antioxidant stress and anticancer activity of peptide‑chelated selenium <em>in vitro</em>
Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expression
Anticancer bioactive peptide suppresses human gastric cancer growth through modulation of apoptosis and the cell cycle